Xylo Technologies Toekomstige groei

Future criteriumcontroles 2/6

Xylo Technologies zal naar verwachting zijn omzet verhogen met 34.4% per jaar.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Medical Equipment winstgroei	17.1%
Inkomstengroei	34.4%
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Low
Laatst bijgewerkt	22 Jul 2024

Recente toekomstige groei-updates

Recent updates

We Believe Medigus' (NASDAQ:MDGS) Earnings Are A Poor Guide For Its Profitability

Sep 28

Medigus jumps 4% as subsidiary Charging Robotics assigns first distributor for its wireless EV robotic charging pad

Jun 17

Medigus launches ADS offering

Jan 11

Medigus expands EV operations with acquisition of autonomous technology, shares up 31%

Jan 08

New finance cheif at Medigus

Dec 01

Medigus shares +42% on plans to enter micro-mobility EV market

Nov 19

Medigus under pressure after increasing stake to ~33% in Polyrizon

Nov 09

Winst- en omzetgroeiprognoses

NasdaqCM:XYLO - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2025	111	N/A	N/A	N/A	1
12/31/2024	105	N/A	N/A	N/A	1
6/30/2024	58	-16	-4	-4	N/A
3/31/2024	75	-16	-6	-5	N/A
12/31/2023	92	-16	-8	-6	N/A
9/30/2023	101	-15	-8	-6	N/A
6/30/2023	110	-14	-8	-6	N/A
3/31/2023	101	-12	-7	-6	N/A
12/31/2022	92	-10	-6	-6	N/A
9/30/2022	67	-8	-5	-5	N/A
6/30/2022	43	-7	-5	-5	N/A
3/31/2022	26	0	-8	-5	N/A
12/31/2021	10	7	-10	-5	N/A
9/30/2021	6	7	-10	-5	N/A
6/30/2021	3	8	-10	-5	N/A
3/31/2021	2	2	-8	-6	N/A
12/31/2020	1	-4	-6	-6	N/A
9/30/2020	0	-10	-5	-5	N/A
6/30/2020	0	-15	-4	-4	N/A
3/31/2020	0	-15	-3	-3	N/A
12/31/2019	0	-14	-3	-3	N/A
9/30/2019	0	-9	-4	-4	N/A
6/30/2019	0	-6	-4	-4	N/A
3/31/2019	0	-6	-4	-4	N/A
12/31/2018	0	-7	-4	-4	N/A
9/30/2018	0	-6	-4	-4	N/A
6/30/2018	0	-4	-4	-4	N/A
3/31/2018	0	-2	N/A	-5	N/A
12/31/2017	0	-3	N/A	-5	N/A
9/30/2017	0	-4	N/A	-5	N/A
6/30/2017	0	-5	N/A	-6	N/A
3/31/2017	0	-8	N/A	-7	N/A
12/31/2016	1	-9	N/A	-9	N/A
9/30/2016	1	-10	N/A	-11	N/A
6/30/2016	1	-10	N/A	-11	N/A
3/31/2016	1	-10	N/A	-10	N/A
12/31/2015	1	-10	N/A	-7	N/A
9/30/2015	1	-8	N/A	-6	N/A
6/30/2015	0	-7	N/A	-6	N/A
3/31/2015	0	-6	N/A	-5	N/A
12/31/2014	1	-6	N/A	-8	N/A
9/30/2014	1	-5	N/A	-7	N/A
6/30/2014	1	-5	N/A	-6	N/A
3/31/2014	1	-2	N/A	-1	N/A
12/31/2013	1	-1	N/A	-7	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van XYLO boven de spaarquote ( 2.6% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van XYLO naar verwachting sneller zal groeien dan de markt US

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van XYLO naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: De omzet van XYLO ( 34.4% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.9% per jaar).

Hoge groei-inkomsten: De omzet van XYLO ( 34.4% per jaar) zal naar verwachting sneller groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van XYLO naar verwachting over 3 jaar hoog zal zijn

Xylo Technologies Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target decreased to US$67.50

Consensus forecasts updated

Recent updates

First half 2024 earnings released: US$11.33 loss per share (vs US$13.39 loss in 1H 2023)

Full year 2023 earnings released: US$9.50 loss per share (vs US$6.04 loss in FY 2022)

Medigus Ltd.(NasdaqCM:MDGS) dropped from NASDAQ Composite Index

New minor risk - Financial data availability

Medigus Ltd. Announces Launch of Unique Pilot of A Wireless Charging Solution

New minor risk - Share price stability

New minor risk - Shareholder dilution

Medigus Ltd., Annual General Meeting, Aug 07, 2023

existing shareholders and office holders in ScoutCam acquired 46.11% stake in ScoutCam Inc. (OTCPK:SCTC) from Medigus Ltd. (NasdaqCM:MDGS) for $6 million.

M. Arkin (1999) Ltd. acquired 46.11% stake in ScoutCam Inc. (OTCPK:SCTC) from Medigus Ltd. (NasdaqCM:MDGS) for $6 million.

Full year 2022 earnings released: US$6.04 loss per share (vs US$4.42 profit in FY 2021)

Medigus Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Price target decreased to US$67.50

Medigus says ScoutCam appoints Yehu Ofer as CEO

Consensus forecasts updated

First half 2022 earnings released: US$0.15 loss per share (vs US$0.44 profit in 1H 2021)

Medigus reports 1H results

What Does Medigus Ltd.'s (NASDAQ:MDGS) Share Price Indicate?

Medigus board files a motion to approve an up to $1.6M dividend distribution

Medigus Announces Receipt of Nasdaq Notice of Bid Price Deficiency

Medigus Ltd., Annual General Meeting, Jun 16, 2022

Is Now An Opportune Moment To Examine Medigus Ltd. (NASDAQ:MDGS)?

Full year 2021 earnings released: EPS: US$0.20 (vs US$0.65 loss in FY 2020)

Medigus Ltd. (NasdaqCM:MDGS) acquired a 35.1% stake in Fuel Doctor Holdings, Inc. (OTCPK:FDOC) for $0.26 million.

Medigus Ltd. Micro Mobility Vehicle JV, Revoltz, Launches Pilot Program At A New Autonomous Supermarket

A consortium of investors led by Medigus Ltd. (NasdaqCM:MDGS), L.I.A. Pure Capital Ltd. along with other buyers including a group of individuals completed the acquisition of ParaZero Technologies Ltd from Delta Drone International Limited (ASX:DLT).

Medigus Ltd. Announces First Authorization for Commercial Drone Deliveries in Brazil

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

High number of new directors

We Believe Medigus' (NASDAQ:MDGS) Earnings Are A Poor Guide For Its Profitability

First half 2021 earnings released: EPS US$0.44 (vs US$0.56 loss in 1H 2020)

Medigus Joint Venture, Revoltz Completes First Micromobility Vehicle Functional Prototype

Medigus jumps 4% as subsidiary Charging Robotics assigns first distributor for its wireless EV robotic charging pad

Medigus Ltd. announced delayed 20-F filing

Medigus Forms Joint Venture for the Development of Urban and Logistics Electric Vehicles with Emuze Founders

Medigus Ltd. Initiates Development of Robotic Wireless Charging Pad for Electric Vehicles

New 90-day high: US$3.69

Medigus launches ADS offering

Medigus Ltd. Enters the Wireless Charging Market for Electric Vehicle with New Autonomous Technology

Medigus expands EV operations with acquisition of autonomous technology, shares up 31%

Medigus Ltd. (TASE:MDGS) completed the acquisition of 50.01% stake in Purex Incorporated and Smart Repair Pro, Inc.

New finance cheif at Medigus

Tatiana Yosef to Step Down as Chief Financial Officer of Medigus Ltd., with Effect from January 15, 2021

Medigus Signs MOU to Enter Electric Vehicles and Electric Charging Market

Medigus shares +42% on plans to enter micro-mobility EV market

Medigus under pressure after increasing stake to ~33% in Polyrizon

Medigus Ltd. (TASE:MDGS) signed a share purchase agreement to acquire an unknown stake in Eventer Technologies Ltd.

Medigus Ltd. (TASE:MDGS) agreed to acquire additional 15.1% stake in Gix Internet Ltd (TASE:GIX).

Medigus Ltd. (TASE:MDGS) signed a non-binding letter of intent to acquire a controlling interest of 50.1% in Purex Incorporated and Smart Repair Pro, Inc. for $2.5 million.

Medigus Ltd. (TASE:MDGS) completed the acquisition of Linkury LTD. from Algomizer Ltd (TASE:ALMO).

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven